Annual report [Section 13 and 15(d), not S-K Item 405]

SEGMENT REPORTING (Tables)

v3.25.0.1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT REPORTING INFORMATION

 SCHEDULE OF SEGMENT REPORTING INFORMATION

Segment Reporting as of and for the year ended December 31, 2024

 

    Treatment     Services     Segments Total     Corporate (1)     Consolidated Total  
Revenue from external customers   $ 34,953     $ 24,164     $ 59,117 (4)(5)   $     $ 59,117  
Cost of Goods Sold:                                        
Payroll and benefits expenses     16,257       9,494       25,751             25,751  
Material and supplies expenses     4,074             4,074             4,074  
Disposal expenses     5,317             5,317             5,317  
Transportation expenses     1,118             1,118             1,118  
Subcontract expenses           7,152       7,152             7,152  
Other cost of goods sold (2)     9,297       6,406       15,703             15,703  
Total cost of goods sold     36,063       23,052       59,115             59,115  
Gross (loss) profit     (1,110 )     1,112       2             2  
Selling, general and administrative expenses (“SG&A”):                                        
Payroll and benefits     2,858       2,413       5,271       3,296       8,567  
Other SG&A (3)     1,432       892       2,324       3,600       5,924  
Total SG&A     4,290       3,305       7,595       6,896       14,491  
Research and development     842       111       953       219       1,172  
Loss on disposal of property and equipment     18       3       21             21  
Loss from operations   $ (6,260 )   $ (2,307 )   $ (8,567 )   $ (7,115 )     (15,682 )
Interest income                                     921  
Interest expense                                     (473 )
Interest expense-financing fees                                     (66 )
Other income                                     166  
Loss from continuing operations before taxes                                     (15,134 )
Income tax expense                                     4,435  
Loss from continuing operations, net of taxes                                   $ (19,569 )

 

 

Segment Reporting as of and for the year ended December 31, 2023

 

    Treatment     Services     Segments Total     Corporate (1)     Consolidated Total  
Revenue from external customers   $ 43,477     $ 46,258       $89,735 (4)(5)   $     $ 89,735  
Cost of goods sold:                                        
Payroll and benefit expenses     14,655       11,800       26,455             26,455  
Material and supplies expenses     3,747             3,747             3,747  
Disposal expenses     6,576             6,576             6,576  
Transportation expenses     1,457             1,457             1,457  
Subcontract expenses           15,555       15,555             15,555  
Other cost of goods sold (2)     10,166       9,410       19,576             19,576  
Total cost of goods sold     36,601       36,765       73,366             73,366  
Gross profit     6,876       9,493       16,369             16,369  
Selling, general and administrative expenses (“SG&A”):                                        
Payroll and benefits     2,438       2,662       5,100       3,812       8,912  
Other SG&A (3)     1,811       834       2,645       3,418       6,063  
Total SG&A     4,249       3,496       7,745       7,230       14,975  
Research and development     418       38       456       105       561  
Loss on disposal of property and equipment           77       77             77  
Income (loss) from operations   $ 2,209     $ 5,882     $ 8,091     $ (7,335 )     756  
Interest income                                     606  
Interest expense                                     (323 )
Interest expense-financing fees                                     (93 )
Other expense                                     (11 )
Income from continuing operations before taxes                                     935  
Income tax expense                                     17  
Income from continuing operations, net of taxes                                   $ 918  

 

(1) Amounts reflect the activity for corporate headquarters not included in the segment reporting information.
   
(2) Other cost of goods sold for each reportable segment includes:
Treatment - lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses.
  Services - material and supplies, disposal and transportation, lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses.
   
(3) Other SG&A for each reportable segment and Corporate includes:
  Treatment-depreciation and amortization, travel, outside services, maintenance and general expenses.
  Services- travel, outside services, maintenance and general expenses.
  Corporate-maintenance, depreciation and amortization, travel, public company, outside services and general expenses.
   
(4) The Company performed services relating to waste generated by federal government clients, either directly as a prime contractor or indirectly for others as a subcontractor to federal government entities, representing approximately $40,550,000 or 68.6% of total revenue for 2024 and $68,595,000 or 76.4% of total revenue for 2023.
   
(5) The following table reflects revenue based on customer location:
SCHEDULE OF REVENUE BASED ON CUSTOMER LOCATION
    2024     2023  
United States   $ 56,665     $ 87,669  
Canada     513       1,685  
Germany     734       206  
Italy     77          
Mexico     394        
Slovenia     181       87  
United Kingdom     553       88  
Total   $ 59,117     $ 89,735  
SCHEDULE OF DEPRECIATION AND AMORTIZATION

The following table presents depreciation and amortization for the years ended December 31, (in thousand):

 

    2024     2023  
Treatment   $ 1,484     $ 2,112  
Services     177       397  
Total segment     1,661       2,509  
Corporate     102       59  
Total   $ 1,763     $ 2,568  
SCHEDULE OF CAPITAL EXPENDITURES

    2024     2023  
Treatment   $ 3,002     $ 1,696  
Services     403       10  
Total segment     3,405       1,706  
Corporate             8  
Total   $ 3,405     $ 1,714  
SCHEDULE OF LONG-LIVED ASSETS FOR CONTINUED OPERATIONS

The following table presents long-lived assets for the Company’s continuing operations for the years ended December 31, (in thousand):

 

    2024     2023  
United States   $ 21,133     $ 19,009  
Foreign Subsidiaries            
Total   $ 21,133     $ 19,009